The Challenging of Chemotherapy among the Cancer Treatments: The Fact and Meth of the Alternative

Main Article Content

Asst. Prof. Dr. Chateen I. Ali Pambuk
Fatma Mustafa Muhammad
Nihad AbdulJabbar Jalal

Abstract

Chemotherapy refers to the role of drugs in trying to destroy or stop the development and spread of cancer cells in the body. Although it is one of the common types of treatment for cancer patients, not all patients need chemotherapy as part of their treatment, as it depends on their specific diagnosis, and sometimes chemotherapy is given only to reduce the size of cancer cells before surgery. Chemotherapy at the Specialized Hospital aims to: Treat cancer diseases and prevent their recurrence.
Controlling cancerous disease by reducing the size of tumors or preventing them from growing and spreading to other parts of the body and relieving symptoms in patients who have cancer spread in their bodies to improve their quality of life and their treatment of cancer

Article Details

How to Cite
Dr. Chateen I. Ali Pambuk, A. P. ., Muhammad, F. M. ., & AbdulJabbar Jalal, N. . (2023). The Challenging of Chemotherapy among the Cancer Treatments: The Fact and Meth of the Alternative . International Journal of Medical Science and Clinical Research Studies, 3(8), 1793–1796. https://doi.org/10.47191/ijmscrs/v3-i8-67
Section
Articles

References

I. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016; 66: 7-30.

II. Verdecchia A, De Angelis G, Capocaccia R. Estimation and projections of cancer prevalence from cancer registry data. Stat Med. 2002; 21: 3511-3526.

III. DeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014; 64: 252-271.

IV. Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012; 62: 220-241.

V. Surveillance Research Program, National Cancer Institute. SEER*Stat software, version 8.2.1. Bethesda, MD: National Cancer Institute; 2015.

VI. Bhargava A, Du XL. Racial and socioeconomic disparities in adjuvant chemotherapy for older women with lymph node-positive, operable breast cancer. Cancer. 2009; 115: 2999-3008.

VII. Lawenda BD, Mondry TE, Johnstone PA. Lymphedema: a primer on the identification and management of a chronic condition in oncologic treatment. CA Cancer J Clin. 2009; 59: 8-24.

VIII. Schover LR, van der Kaaij M, van Dorst E, Creutzberg C, Huyghe E, Kiserud CE. Sexual dysfunction and infertility as late effects of cancer treatment. EJC Suppl. 2014; 12: 41-53.

IX. Bleyer A. Young adult oncology: the patients and their survival challenges. CA Cancer J Clin. 2007; 57: 242-255.

X. Albritton K, Barr R, Bleyer A. The adolescence of young adult oncology. Semin Oncol. 2009; 36: 478-488.

XI. Hudson MM, Ness KK, Gurney JG, et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA. 2013; 309: 2371-2381.

XII. Ferdinand R, Mitchell SA, Batson S, Tumur I. Treatments for chronic myeloid leukemia: a qualitative systematic review. J Blood Med. 2012; 3: 51-76.

XIII. Faderl S, Jeha S, Kantarjian HM. The biology and therapy of adult acute lymphoblastic leukemia. Cancer. 2003; 98: 1337-1354.

XIV. Shankland KR, Armitage JO, Hancock BW. Non-Hodgkin lymphoma. Lancet. 2012; 380: 848-857.

XV. Karimkhani C, Gonzalez R, Dellavalle RP. A review of novel therapies for melanoma. Am J Clin Dermatol. 2014; 15: 323-337.